How should I manage a high‑normal sex hormone‑binding globulin (SHBG) level in a 39‑year‑old, 6′3″, 170 lb man on testosterone replacement therapy (TRT) who has normal total testosterone, elevated free testosterone, and otherwise normal endocrine labs?

Management of Elevated SHBG with Normal Total Testosterone in a Symptomatic 39-Year-Old Man

This patient does NOT meet diagnostic criteria for hypogonadism and should NOT receive testosterone replacement therapy. His total testosterone of 828 ng/dL is well above the diagnostic threshold of 300 ng/dL required on two separate morning measurements, and testosterone therapy is not indicated regardless of SHBG levels when total testosterone exceeds 350 ng/dL. 1

Understanding the Laboratory Picture

The elevated SHBG (57 nmol/L) is binding a larger proportion of his testosterone, but his total testosterone remains robustly normal. The free testosterone of 73.8 pg/mL appears adequate for a man of his age, though interpretation depends on the assay used and whether this represents true equilibrium dialysis measurement or a calculated value. 2, 3

• SHBG elevation can result from multiple causes: liver disease (including cirrhosis), hyperthyroidism, HIV infection, certain medications (anticonvulsants, estrogens), smoking, and aging. 1
• His very lean body habitus (6'3", 170 lbs, BMI ≈ 21.2) may contribute to relatively higher SHBG, as obesity typically suppresses SHBG while leanness can elevate it. 1

Diagnostic Workup to Identify Reversible Causes

Before considering any intervention, systematically evaluate for treatable conditions causing elevated SHBG:

• Thyroid function: Measure TSH and free T4 to exclude hyperthyroidism, which directly increases hepatic SHBG synthesis. 1
• Liver function: Obtain comprehensive hepatic panel (AST, ALT, alkaline phosphatase, bilirubin, albumin) and hepatitis serologies to rule out chronic liver disease. 1
• Medication review: Identify any anticonvulsants, thyroid hormone supplementation, or other SHBG-elevating drugs. 1
• HIV screening: Consider risk-based testing if appropriate. 1

Calculating Free Androgen Index for Better Assessment

When SHBG is abnormal, the free androgen index (FAI) provides a more accurate assessment of androgen exposure than total testosterone alone:

• FAI = (Total Testosterone ÷ SHBG) × 100 1
• For this patient: (828 ng/dL ÷ 28.8 ng/mL conversion × 57 nmol/L) = FAI calculation requires unit conversion
• An FAI < 30 indicates true functional hypogonadism even with borderline-normal total testosterone. 1
• If equilibrium dialysis free testosterone measurement is available (the gold standard), request it to definitively assess bioavailable androgen. 1, 3

Addressing the Clinical Symptoms

The patient's symptoms—fatigue, low energy, poor recovery, low libido—are nonspecific and show minimal correlation with testosterone levels in men with normal total testosterone:

• Testosterone therapy produces little to no benefit for energy, vitality, or physical functioning even in confirmed hypogonadism (total testosterone < 300 ng/dL). 1
• The effect size for fatigue improvement is clinically insignificant (standardized mean difference 0.17) even when hypogonadism is present. 1
• Low libido is the only symptom with proven testosterone responsiveness, but therapy is justified only when biochemical hypogonadism is confirmed. 1

Alternative explanations for his symptoms should be systematically explored:

• Sleep disorders: Screen for obstructive sleep apnea (common in physically demanding occupations) and assess sleep quality/duration. 1
• Overtraining/inadequate recovery: His manual labor job provides constant physical stress without structured recovery; consider whether he needs periodized rest rather than hormonal intervention. 1
• Nutritional deficiencies: At 170 lbs and 6'3" with high physical demands, evaluate for inadequate caloric intake, vitamin D deficiency, iron status, and overall macronutrient balance. 1
• Metabolic syndrome screening: Obtain fasting glucose, HbA1c, and lipid panel to exclude insulin resistance or prediabetes. 1
• Thyroid dysfunction: Beyond SHBG evaluation, thyroid disorders directly cause fatigue and low energy. 1
• Anemia: Check complete blood count, as unexplained anemia warrants testosterone measurement but also requires its own workup. 1

Why Testosterone Therapy Is Contraindicated

Multiple guideline-based reasons preclude testosterone replacement in this patient:

• The European Association of Urology explicitly recommends against testosterone therapy in eugonadal men (normal testosterone levels), even for weight loss, cardiometabolic improvement, cognition, vitality, or physical strength. 1
• Total testosterone > 350 ng/dL does not warrant substitution regardless of symptoms. 4
• Approximately 20-30% of men receiving testosterone in the United States do not meet diagnostic criteria for hypogonadism—a practice pattern that violates evidence-based guidelines. 1
• Starting testosterone without confirmed biochemical hypogonadism (two morning measurements < 300 ng/dL) risks unnecessary exposure to adverse effects including erythrocytosis (44% risk with injectables), cardiovascular events, and permanent fertility suppression. 1

Evidence-Based Management Algorithm

Step 1: Complete the diagnostic evaluation for elevated SHBG

• Measure TSH, free T4, comprehensive hepatic panel, and consider HIV testing based on risk factors. 1
• Calculate free androgen index or obtain equilibrium dialysis free testosterone if available. 1, 3

Step 2: Address identified reversible causes

• Treat hyperthyroidism if present. 1
• Optimize liver function if hepatic disease is detected. 1
• Discontinue or substitute SHBG-elevating medications when feasible. 1

Step 3: Systematically evaluate alternative causes of symptoms

• Sleep study if obstructive sleep apnea is suspected. 1
• Nutritional assessment and optimization (consider registered dietitian referral given high physical demands and lean body mass). 1
• Screen for metabolic syndrome, anemia, and vitamin D deficiency. 1

Step 4: Implement lifestyle and recovery optimization

• Structured rest and recovery: Periodize physical demands with adequate rest days. 1
• Nutritional adequacy: Ensure caloric intake matches expenditure (likely 3000+ kcal/day given his occupation and body composition). 1
• Sleep hygiene: Target 7-9 hours of quality sleep nightly. 1
• Stress management: Address psychological stressors that may contribute to fatigue and low libido. 1

Step 5: Reassess symptoms after 3-6 months

• If symptoms persist despite addressing reversible causes and optimizing lifestyle factors, consider referral to endocrinology for specialized evaluation. 1
• Do NOT initiate testosterone therapy unless repeat morning measurements document total testosterone < 300 ng/dL on two separate occasions. 1

Critical Pitfalls to Avoid

• Do not diagnose hypogonadism based on symptoms alone or elevated SHBG without confirmed low total testosterone. 1
• Do not prescribe testosterone for energy enhancement, athletic performance, or body composition goals in eugonadal men—these are not evidence-based indications. 1
• Do not rely on direct immunoassays for free testosterone in men with abnormal SHBG; use equilibrium dialysis or calculated free androgen index. 1
• Do not assume that "normal" total testosterone with elevated SHBG automatically justifies treatment—the threshold remains two morning measurements < 300 ng/dL. 1
• Recognize that up to 25-30% of men on testosterone therapy do not meet diagnostic criteria, representing inappropriate prescribing. 1

Expected Outcomes If Reversible Causes Are Addressed

If an underlying condition (hyperthyroidism, liver disease, nutritional deficiency, sleep disorder) is identified and treated, symptoms often improve without hormonal intervention. 1 Weight loss and lifestyle modification can improve testosterone levels in obesity-associated hypogonadism, though this patient's lean body mass suggests a different mechanism. 1

The patient should understand that even if he had confirmed hypogonadism, testosterone therapy would provide only modest improvements in sexual function (standardized mean difference 0.35) with no meaningful benefit for energy, physical performance, or mood. 1